Therefore, the present study seeks to elucidate the functional mechanism of the ASNS/Asn/mTORC1/ASNS positive feedback loop and highlights NEK8 as a potential therapeutic target for Asn restriction therapy in GC. The gene discussed is NEK8; the disease is gastric cancer.